We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BLRX Initiates Phase 2a Trial of BL-8040 with KEYTRUDA®

News   Sep 21, 2016

 
BLRX Initiates Phase 2a Trial of BL-8040 with KEYTRUDA®
 
 
Advertisement
 

RELATED ARTICLES

UK Government-Funded COVID-19 Vaccine Phase 1/2 Trials Report Positive Data

News

A new COVID-19 vaccine candidate – VLA2001 – developed by Valneva has shown positive results in a UK Government-funded Phase I/II clinical trial, according to a press release.

READ MORE

An Epigenetic Signature for COVID-19 Severity?

News

An article published in the journal EBiomedicine by the group of Dr. Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute and Dr. Aurora Pujol, head of the Neurometabolic Diseases Group of the Bellvitge Biomedical Research Institute (IDIBELL), shows that the epigenetic endowment of each person influences the severity of the COVID-19 disease.

READ MORE

New Method Directly Measures the Growth Rate of Amyloid Fibrils

News

Amyloid fibrils are protein deposits in the body that join together to form microscopic fibres. Their formation has been linked to many serious human diseases including Alzheimer's, Parkinson's and Type 2 diabetes. Researchers have now invented a technique that can measure the speed of fibril growth in solution.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE